Table 1.

Baseline Demographics

	DaxibotulinumtoxinA dose
	100–240 U (N = 21)	300–450 U (N = 16) a	100–450 U (N = 37) (Combined group)
Mean age ± SD, yrs	54 ± 10.4	58 ± 10.6	56 ± 10.4
[range]	[32–74]	[30–70]	[30–74]
Females, n (%)	18 (86%)	10 (63%)	28 (76%)
Caucasians, n (%)	18 (86%)	14 (88%)	32 (86%)
Duration of cervical dystonia, yrs
Mean ± SD	7.3 ± 8.09	7.9 ± 7.13	7.6 ± 7.59
Median [range]	4.8 [0.0–24.1]	7.2 [0.0–23.3]	4.9 [0.0–24.1]
Prior treatment with botulinum toxin, n	9 (43%)	8 (50%)	17 (46%)
Mean dose of daxibotulinumtoxinA ± SD, U	188 ± 35.1	319 ± 39.3	244 ± 75.4
Mean TWSTRS score ± SD
Total score	44.4 ± 9.52	43.8 ± 10.20	44.1 ± 9.69
Severity subscore	20.5 ± 3.23	21.9 ± 3.89	21.1 ± 3.55
Disability subscore	12.6 ± 3.92	11.6 ± 4.51	12.2 ± 4.15
Pain subscore	11.3 ± 4.63	10.3 ± 4.55	10.8 ± 4.56
CDIP‐58 total score
Mean ± SD	53.9 ± 18.76	49.7 ± 14.90	52.1 ± 17.10
Median [range]	51.4 [22.8–90.7]	55.9 [23.5–71.7]	54.8 [22.8–90.7]

Abbreviations: CDIP‐58, Cervical Dystonia Impact Profile; SD, standard deviation; TWSTRS, Toronto Western Spasmodic Torticollis Rating Scale

^aThree were reenrolled from lower‐dose group.